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Identification of SNPs potentially associated with di-isocyanate asthma using a 
luciferase reporter assay 
Wentao Jiang 
 
Occupational Asthma (OA) is a common lung disorder that can be caused or 
aggravated by exposures and conditions in the work places. Di-isocyanate asthma (DA) 
is one type of OA. Despite years of research, there are no reliable markers to predict 
risk or susceptibility for DA. Previous studies have identified 23 candidate single 
nucleotide polymorphisms (SNPs) that are potentially associated with genes that are 
related with DA. In this study, we tested the functional relevance of the 23 candidate 
SNPs (mostly intronic) in several DA-related genes. We hypothesized that some of 
these SNPs may affect the binding of relevant transcription factors, causing altered 
expression of these genes. We inserted short DNA fragments (~30 bp) containing the 
SNPs and long DNA fragments containing multiple SNPs into the pGL3-promoter 
firefly luciferase reporter vector and transfected them into adenocarcinomas human 
alveolar basal epithelial cells (A549 cell line). The expression levels of different SNP 
constructs were measured by luciferase reporter assay. Our results showed that 3 SNPs 
(rs11571537, rs2287231 and rs2446824) that are located in ATF3, TAR1 and CDH17 
genes, respectively, had significant difference in luciferase activities between risk and 
non-risk alleles (C vs. T for rs11571537, A vs. G for rs2287231, and T vs. C for 
rs2446824). Our data indicate that the SNPs we found may affect the expression of 
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Occupational Asthma (OA) is one type of asthma that is work-related. It is the 
most common lung disorder in many developed countries (Meyer et al., 1999；
Contreras, Rousseau and Chan-Yeung, 1994；Reijula and Patterson, 1994). This disease 
can be caused or aggravated by exposures and conditions in the workplaces. OA has 
two main types: immunologic and non-immunologic. It can be differentiated by the 
appearance after a latency period. Di-isocyanate asthma (DA) is one type of 
immunological asthma caused by isocyanate chemicals. Di-isocyanate chemicals are a 
family of chemical building blocks mainly used to make polyurethane products. 
Toluene di-isocyanate (TDI) and methylene diphenyl di-isocyanate (MDI) are the main 
di-isocyanates. TDI is used in the production of flexible foams. MDI is used in the 
production of a variety of polyurethane products like elastomers, sealants, adhesives, 
and coatings (McDonald, 2000). The isocyanates have become the most common agent 
causing OA, and nearly 10 percent OA cases are due to the isocyanate chemicals (Chan-
Yeung and Malo, 1995). 
SNPs are the most common form of genomic variations. They occur once every 
several hundred base pairs throughout the human genome. The vast majority of SNPs 
are neutral allelic variants. However, the few that do influence a phenotype in a 
measurable way are important for understanding the underlying genetics of human 
health. SNPs can be divided into three types. They may fall within coding sequences of 
genes, non-coding regions of genes, or in the intergenic regions. Synonymous and 
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nonsynonymous SNPs are SNPs in the coding region. Synonymous SNPs do not affect 
the protein sequence while nonsynonymous SNPs change the sequence of the protein. 
SNPs that are not in protein-coding regions are called eSNPs (expression SNPs). They 
may still affect gene splicing, transcription factor binding, messenger RNA degradation, 
or the sequence of non-coding RNA (Katkoori, 2008).  
Several genes, as well as environmental factors, have shown interactions with 
OA (Mapp, 2003). OA is a good model for investigating the gene-environment 
interactions (Park and Frew, 2002). To find the gene interaction with a specific disease, 
linkage analysis is the way for identifying genetic regions which may cause disease. 
Using candidate loci linkage disequilibrium mapping, finding single nucleotide 
polymorphisms (SNPs) on suspicious genes might be helpful to understand 
mechanisms of asthma (Palmer and Cookson, 2001). A preliminary study recruited 
workers with occupational asthma caused by di-isocyanates at occupational health 
clinics in Canada and Spain. The next-generation sequencing was performed in 91 
workers with confirmed DA (cases) and compared to 293 subjects with sequencing data 
from the 1,000 genomic (1KG) control data set and 143 significant SNPs associated 
with DA were found (Lummus et al., 2017). 
In this study, we examined top-ranked 23 SNPs from the preliminary study 
(Table 1) to evaluate their effort on gene expression. We hypothesized these SNPs may 
contain potential transcriptional elements that may affect transcriptional factor binding, 
thus affecting gene expression. The candidate genes are known to have strong 
relationships with di-isocyanates induced occupational asthma (Table 2). The main 
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purpose of this study was to identify SNPs that may affect the expression level of these 





1. Occupational Asthma 
 
History and Definition 
Occupational asthma (OA) is a common lung disorder. It is one of the most 
common occupational lung diseases in many industrialized countries (Meredith and 
Nordman, 1996). OA is worth to study because it has the potential to provide the 
information about the effect of genetic, environmental and behavioral interactions in 
onset of asthma (Maestrelli, 2004). Although OA was recognized in the early 18th 
century, the definition of OA has met with difficulty until more recently. From textbook, 
it briefly defines: occupational asthma is a disease characterized by variable airflow 
limitation and/or airway hyperresponsiveness due to causes and conditions attributable 
to a particular occupational environment and not to stimuli encountered outside the 
workplace (Chan-Yeung, 1995). There are two types of OA; they are differentiated by 
the appearance after a latency period-immunologic and nonimmunologic. Immunologic 
OA appears after a variable period of worker exposure in causal agent and acquires 
immunologically mediated sensitization. Immunologic asthma can be classified into 
that caused by high-molecular or low-molecular-weight compounds. The high-
molecular-weight (>5000 DA) compounds are an animal and plant proteins or 
polysaccharides such as wheat flour and animal dander that cause an Immunoglobulin 
E (IgE)-dependent immune response. The low-molecular-weight (<5,000 DA) 
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compounds are chemicals such as di-isocyanates and western red cedar that can also 
initiate an immune response after repeated inhalation. While non-immunologic OA 
appears without a latent period, it happens after exposure to high concentration of 
workplace irritant. This reaction also called Irritant-induced asthma clinically (Bardana, 
1999) (Tarlo and Broder, 1989). The airway dysfunction syndrome (RADS) is typical 
irritant-induced asthma, which may occur after a single exposure to high levels of an 
irritating vapor, fume, or smoke (Brooks, Weiss and Bernstein, 1985).  
 
Epidemiology and Pathophysiology 
In recent years, many large population-based studies of OA and information on 
the occupation have been carried out. Such investigations point the risk of OA and 
contribute to studies of OA. OA accounted for 26% of all work-related respiratory 
disease reported to the Surveillance of Work and Occupational Respiratory Disease 
(SWORD) program in the UK (Bakerly et al., 2008). In the United States, the analysis 
of 1978 social security disability data point around 15% of asthma is attributed to 
workplace exposure (Blanc, 1987). Moreover, six communities in Canada showed the 
frequency of possible OA was as high as 36.1% (Allen, 2002).  
Inhaled agents (High-molecular-weight or Low-molecular-weight) in a 
workplace environment could lead to asthma by sensitization, normally, by creating 
airway inflammation or by irritant reflex pathways. Until now, more than 250 agents 
have been defined as causing immunologic OA (Chan-Yeung and Malo, 1994). The 
pathophysiology of immunologic OA can be divided as IgE-Dependent and IgE 
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Independent. Most high-molecular-weight agents such as flour and animal or plant 
protein induce asthma by producing IgE antibodies. Some specific low-molecular-
weights agents such as platinum salts and acid anhydrides also induce IgE antibodies, 
may acting as haptens, working with body protein to form functional antigens (Baur 
and Czuppon, 1995) (Biagini et al., 1985). The unique IgE antibodies on the surface of 
different types of cells (Mast cell, Eosinophil, Macrophage, Neutrophil, dendritic cell, 
etc.) combine with allergens giving rise to a cascade of events which result in cell 
inflammation or form inflammatory mediators causing inflammation reaction. Other 
low-molecular-weight agents such as isocyanates and plicatic acid can cause OA 
without consistently induce IgE antibodies, the pathophysiology is still unclear (Sastre, 
Vandenplas and Park, 2003). The mechanism of RADS is unknown. It has a postulation 
that extensive denudation of the epithelium results in airway inflammation (Leroyer et 
al., 1998).  
 
Diagnosis and Management 
      The diagnosis of OA has to establish a relation between asthma and work (Anees, 
2003) (Moscato, Malo and Bernstein, 2003). It should be based on a compatible history 
and the presence of variable airflow limitation and lung volume. Making diagnosis need 
the presence of both intermittent respiratory symptoms such as cough, chest tightness, 
wheezing and physiologic evidence of reversible airways obstruction or 
hyperresponsiveness. A non-specific bronchial hyperreactivity test is one way be used 
to help diagnose occupational asthma. The IgE test is performed to evaluate whether 
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the subject is allergic to specific substances (de Groene et al., 2012). A spirometer also 
can use to measure timed expired and inspired volumes can help to diagnose 
occupational asthma. It is important to realize that no single test can diagnosis OA. The 
best way to manage OA is the removal of the worker from further exposure and making 
a substituted environment. If the substitution is not possible, changing the ventilation 
system in the workplace or ongoing maintenance of engineering control are necessary. 
Anti-inflammatory agents like corticosteroids, LKTRA or mast cell stabilizers can be 
used depending on the severity of the case. 
 
2. SNPs and GWAS study 
 
SNPs 
      Single-nucleotide polymorphism (SNP) is a variation in a single nucleotide of 
a DNA sequence at a specific position. It is occurring when a single nucleotide in the 
genome or other shared sequence differs between members of a species or paired 
chromosomes in an individual. The nucleotides change from purine to purine called 
transition and from purine to pyrimidine called transversion. For example, two DNA 
sequence fragments from different individuals, ACAGCTA to ACACCTA, contain one 
single nucleotide difference. Most common SNPs have two alleles. In this case, there 
are two alleles: G and C. There is always different frequency between two alleles, the 
one with lower frequency at a locus in a specific position called minor allele, while the 
one with a higher frequency called major allele. Single nucleotides can be changed 
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(substitution), removed (deletions) or added (insertion) to a polynucleotide sequence. 
SNPs may be located on the coding, non-coding or intergenic region. Even if SNPs 
locate on the coding region, it does not mean amino acid sequence change. This type of 
SNPs can encode the same amino acid sequence, amking it a synonymous SNP. If a 
different amino acid is produced, the SNPs is termed nonsynonymous. SNPs may also 
generate stop codons, in this case, they are termed nonsense. SNPs that do not locate in 
protein-coding regions may still have consequences for gene splicing, transcription 
factor binding, or the sequence of non-coding RNA. SNPs occur once in every 300 
nucleotides on average, which means there are nearly 10 million SNPs in the human 
genome. Normally, these variations are found in the DNA between genes. They can act 
as molecular markers, helping scientists locate genes that are associated with the disease. 
When SNPs occur within a gene or in a regulatory region near a gene, they may play a 
more direct role in disease by affecting the gene’s function.  
 
GWAS 
      For years, researchers have tried to use genetic markers to identify genetic risk 
factors for common and complex human disease. Genome-wide association study 
(GWAS) is a powerful tool for the examination of a genome-wide set of genetic variants 
in different individuals to see if any variant is associated with a phenotype or trait. The 
ultimate goal of GWAS study is to use genetic risk factors to make predictions about 
one individual is at risk and to identify the biological cornerstone of disease 
susceptibility for developing prevention even treatment strategies (Bush and Moore, 
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2012). SNPs are ideal markers for GWAS study, because SNPs are notably a type of 
common genetic variation; it is easy to find a relation between genotype and phenotype.  
      How to capture common variation? There is a hypothesis named common 
disease/ common variant (CD/CV) that states common disorders are likely influenced 
by genetic variation that is also common in the population (Bush and Moore, 2012). 
Over a five-year test of this CD/CV hypothesis, for most of the common diseases, this 
hypothesis is true. Based on this hypothesis, a project named Human Haplotype Map 
(HapMap) builds a systematic approach to interrogate the common variation in the 
human genome; the project included 11 human population with genotypes of 1.6 
million SNPs (Altshuler et al., 2010). Because of the HapMap genotype data, the 
examination of linkage disequilibrium (LD) is available. LD is a property of SNPs on 
a stretch of genomic sequence that describes the degree to which an allele of one SNP 
is inherited or correlated with an allele of another SNP, or even more than two SNPs 
within a population. There are two common approaches to measuring LD: D’ and r2; 


















P represents the frequency, if r2 is high, it means two or more SNPs convey similar 
information and only one of SNPs needs to be genotyped to capture the allelic variation. 
LD can prevent genotyping SNPs provide redundant information.  
     Combining all the information from HapMap and LD analysis, and other details 
such as indirect association, the chip-based microarray technology makes possible 
assaying one million or more SNPs for GWAS research. The two most famous 
platforms for GWAS are Illumina (San Diego, CA) and Affymetrix (Santa Clara, CA). 
However, it is important to note that the genomic variation measurement changing 
rapidly, more secrets of human disease phenotype will find its linking line with 
genotype.  
      The primary approach of GWAS is the case-control setup. It compares two 
large groups of individuals, one healthy control group and one case group with the 
disease. All individuals in each group are genotyped for the majority of common known 
SNPs. If the allele frequency is significantly different between the case and the control, 
the SNPs then need to do more investigations. In such setups, the odds ratio will show 
the effect size. The odds of disease for individuals having a specific allele and the odds 
of disease for individuals who do not have that same allele divide together. The odds 
ratio is higher than one if the allele frequency in the case group is much higher than in 
the control group, and vice versa. Additionally, a P-value for the significance of the 
odds ratio is typically calculated using a simple chi-squared test. Finding odds ratios 
that are significant is prove of the SNPs is associated with the disease.  
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      From the development of GWAS, we can tell this study has a huge impact on 
the field of human genetics and the knowledge of the common human disease. In the 
future, large data management system and cheap sequencing technologies will help 
GWAS go up to a higher level.  
 
Genes related to occupational asthma 
      Genetic factors that relate with occupational asthma have begun to be explored 
for a long time (Mapp et al., 1994). Understanding the interaction between genetic 
factors and the environment is the best way to characterize OA. The first pool or gene 
family found associated with OA is major histocompatibility complex genes on 
chromosome 6p. It encodes the HLA class II molecules that requires binding of antigen 
to a T-cell receptor to start a series cascade reaction for antibody response. The major 
histocompatibility complex class II proteins are the important factors for the specific 
response to occupational agent, such as di-isocyanates, acid anhydrides, natural rubber 
latex, western red cedar and animal proteins (Horne et al., 2000) (Rihs et al., 2002) (Jeal 
et al., 2003). One research study indicates that about 40% of OA in the population 
examined could be attributed to an HLA-DRβ1*07 phenotype (Jeal et al., 2003). In 
general, HLA class II molecules provide evidence of a specific immunologic response 
in asthma induced by low-molecular-weight reagents.  
      The second pool of genes is the superfamily of glutathione S-transferase (GST). 
It comprises a family of eukaryotic and prokaryotic phase II metabolic isozymes best 
known for their ability to catalyze the conjugation of the reduced form of glutathione 
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to xenobiotic substrates for the purpose of detoxification. This family mainly function 
is protecting cells from oxidative stress products. One research indicates that patients 
who exposed to TDI for 10 or more years have a lower frequency of the GSTP1 Val/Val 
genotype compared to the subjects who had asthma. Data suggest that homozygosity 
for the GSTP1*Val allele confers protection against TDI-induced asthma and airway 
hyperresponsiveness (Mapp et al., 2002). Moreover, besides GST, N-acetyltransferase 
genotypes can slow down acetylation genotypes posed a 7.77 fold greater risk of asthma, 
especially TDI-induced asthma (Wikman et al., 2002). Because OA is not a simple 
clinical disease but has to consider multiple factors, efforts should be made to use the 
genetic information carefully. 
 
3. Eukaryotic Transcription Regulation 
 
      Transcription regulation means the controls during the conversion from DNA to 
RNA, thereby orchestrating gene activities. In a eukaryote, the phenotypic differences 
that distinguish the many types of cells are majorly due to differences in the expression 
of genes that code for proteins. The transcription processes play an important role in 
the regulation of gene expression. Six potential control points during transcription by 
RNA polymerase II are from the following series: activation of gene structure (open 
chromatin), initiation and elongation, processing transcription, transport to the 
cytoplasm from the nucleus, translation, degradation and turnover to mRNA. 
Eukaryotes have three RNA polymerases: Pol I, Pol II, and Pol III. Each of these three 
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polymerases has specific targets and activities. They can work with each other or be 
regulated by independent mechanisms. The mechanisms can be grouped into three areas: 
(1) Gates for polymerases access to genes. This includes the functions of histone 
remodeling enzymes, enhancers and repressors, transcription factors, and many other 
complexes. (2) The engine of elongation. It can help to escape the promoter complex 
and making a productive elongation. (3) The brake of transcription. Many factors can 
control when and how termination occurs. All three of this system working accordingly 
and making transcription accomplish successfully. Unlike prokaryotic system, 
eukaryotes have a restrictive basal state which requires the recruitment of other factors. 
This difference is largely due to the compaction of the eukaryotic genome by winding 
DNA around histones to form higher order structures. 
 
Relationship of Chromatin Structure to Transcription 
      In eukaryotes, the DNA is not “naked,” instead, it highly packed as chromatin 
to fit in the nucleus. This process is accomplished by wrapping DNA on an octamer 
structure protein called histone. The one single histone wrapped with 146 base pair of 
DNA is nucleosome. It is basic units of chromatin. With these highly packed 
characteristics, eukaryotes genes are at default status “silence.” To activate gene 
expression, that is, initiation transcription, the chromatin structure should be opened. 
The change of structure precedes the act of transcription and indicates that the gene can 
be transcribed. Chromatin remodeling is the general process of inducing changes in 
chromatin structure. It requires repositioning or displacing histones through recruiting 
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energy. There are several types of chromatin remodeling: (1) Histone slides along DNA. 
This can alter rotationally and the translational position of the particular sequence on 
the nucleosome. (2) The spacing may change between two octamer histones. (3) The 
octamer histones may displace entirely thereby releasing “naked” DNA. The histone 
structure has a pair of tails on the end of core histone, which can be modified by histone 
acetyltransferases (HATs), histone methyltransferases (HMTs), and histone 
deacetylases (HDACs), etc. These enzymes can add or remove covalent modifications 
such as methyl groups, acetyl groups, phosphates, and ubiquitin. Usually, histone 
acetylation is associated with transcription activation, and deacetylation is associated 
with repression. As for methylation, generally, represents a feature of inactive 
chromatin. However, some methylation also can activate transcription, such as di- or 
tri-methylation of H3K4 is associated with transcriptional activation. Histone 
phosphorylation also can affect chromatin structure, linking with transcriptional 
repairing, chromosome condensation, and cell-cycle progression. 
 
Activators and Repressors 
      The initiation of transcription requires a complicated protein-protein interaction 
system that features transcription factors bound at enhancers with the basal apparatus 
that assembles at the promotor including the RNA polymerase. The transcription factors 
may stimulate transcription or delay transcription, the one with a positive effect called 
activators, the one with a negative effect called repressors.  
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Activators can be classified into three types by its function. The first class of activator 
is true activator which contacts with basal apparatus at promotor either directly or 
indirectly by co-activator. They all function on DNA or chromatin template. The second 
class is the anti-repressor. It functions to unwind chromatin from closed status to open 
status by recruiting the histone modifier enzymes or the chromatin remodeling 
complexes. It can only function on chromatin template. The third class is architectural 
proteins that can bend strand DNA and bring two or more functional areas together. 
Regarding repressor, there are four possible illustrations of the mechanism. First, is 
sequestering an activator in the cytoplasm, the repressor will mask activator pass 
through the cytoplasm. The second one is repressor in nucleus masks activators which 
have already bind on promotor. Third is repressor masking and holding in the cytoplasm 
until it is released to enter the nucleus. The last one is competing with the enhancer.  
      In many cases, activators may not bind directly at the promotor area because 
they lack a transcription activation domain. However, they can bind another protein that 
has a transcription activation domain. An activation domain works by making protein-
protein interaction contacts with general transcription factors that promote assembly of 
basal apparatus. Basal apparatus contains basal factor: TFIID, TFIIB, or TFIIA. All 
components required for efficient transcription are basal apparatus, RNA polymerase, 
activators, and co-activators. This component consists of ~40 proteins. They will 








4. Luciferase Assay 
 
      Luciferase is a class of oxidative enzymes that produce bioluminescence. Using 
this characteristic, researchers found a powerful and adaptable tools for cell biology 
research-luciferase assay. It is commonly using on eukaryotic gene expression at 
transcription level due to its convenience, relatively inexpensive and instantaneously 
quantitative measurement. Luciferase assay technology can be applied to many areas. 
      It is important to find optic-reporter genes for the research of gene expression 
and cellular events during the gene expression. Typically, a reporter gene should be 
cloned with a DNA sequence of interest into an expression vector thereby transfect to 
the specific cells. A good reporter gene is easy to be identified and can be measured 
quantitatively. For a long time finding of bioluminescence, the luciferase from firefly 
(Photinus Pyralis) and renilla (Renilla reniform) are well known in detail and 
commonly using for dual-reporter assays. The reason to use dual-reporter assay is to 
improve experimental accuracy. The “dual reporter” represents two individual reporter 
enzymes within a single system measured and expressed simultaneously. Because 
typically the experimental condition should be the same, the co-transfection of two 
enzymes can act as an internal control and serve a baseline response. Normalizing the 
activity of the experimental reporter to the activity of the internal control minimizes 
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experimental variability caused by differences in cell viability or transfection efficiency. 
Through the dual reporter system, the external influence of experiment can be largely 
removed. Also, because of the difference between Firefly and Renilla luciferases 
enzyme structures and substrates requirements, makes it possible to selectively 
discriminate between their bioluminescence reactions. Firefly luciferase is a 61 kDa 
monomeric protein, and Renilla luciferase is a 36 kDa monomeric protein. They both 
do not require post-translational processing for enzymatic activities (Wood et al., 1984) 
(de Wet et al., 1985). Thus, they can function as a reporter immediately. The reactions 
of both Firefly and Renilla luciferase show in Figure 1.  
      Luciferase assay has been developed for many research applications. The most 
common application of luciferase assay is analyzing the function of cis-acting genetic 
elements, especially promoters. Deletion or mutation will be made on promoter regions 
and then measured by luciferase assay. For example, the human factor VIII gene 
promoter region was found through luciferase assay, which contains around 200bp 
(Figueiredo and Brownlee, 1995). The second application is focused on SNPs 
researches. Through comparing two different allele luciferase activities, the functional 
allele can be recognized. The real power of luciferase technology comes from its ability 
to be used as cellular readouts for virtually any signaling event. By coupling a response 
element controlled by the signaling event of interest to luciferase, researchers can point 
the intracellular events due to quantified analysis. Luciferase assay can also help 
research of RNA interference (RNAi). Once the reporter assay cell line established, the 
signaling pathway of specific molecules can be detected.  
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      Those applications mentioned before are just a few of the broad range of 
luciferase assay application. It is clear that the luciferase assay is a powerful and 
versatile tool for gene expression studies as well as studies of other cellular components 
and events.  
 
Objectives of the Study 
      A next-generation DNA sequencing analysis of di-isocyanate asthma cases 
compared to control was made by a preliminary study. Twenty-three out of one 
hundreds and forty-three SNPs were identified for further study. The SNPs are 
contained in seven loci: CDH17 (10), ATF3 (6), FAM71A (2), PITPNC1, TACR1, 
ZBTB16, LOC101929565. Based on the locations of the 23 SNPs, many of them are 
located near each other. So we also designed two haplotypes long fragments containing 
those linked SNPs as two new samples. In total, we have twenty-three SNPs and two 
long fragments that contain several SNPs for this study. We hypothesized that some of 
those risk SNPs will affect the binding of the relevant transcription factors which may 
cause the expression changes of DA-related genes. The specific goal is to determine if 
any of the risk SNPs are located in putative transcriptional elements that may affect the 
binding of the relevant transcription factors which may change expression of genes 




Material and Method 
 
SNP fragment design and annealing 
      Forty-six pairs of DNA oligonucleotides were designed and ordered from oligo 
making company (Integrated DNA Technologies, Inc. IA) according to twenty-three 
SNPs show on Table 1. For each SNP, two pairs of oligonucleotides around 25 
nanomole DNA oligonucleotides having XhoI and KpnI restriction sites that contain 
risk allele or non-risk allele were designed, an example of fragment design is shown in 
Figure 2. Each oligo was spun down by mini centrifuge for 1 minute and diluted to 100 
nM with molecular biology grade water. Forty-six pairs of oligonucleotides then were 
incubated at 4℃ for one hour. For oligonucleotides annealing, each pair of 
oligonucleotides were added 10 ul into PCR tube separately. PCR tubes later were 
incubated in a PCR machine at 95℃ for 5 minutes and then cooled down to room 
temperature (25℃) over 45 minutes. All tubes were kept in 4℃ fridges for storage until 
use. Table 4 lists all 23 SNP insert sequences.  
 
PCR amplification and gel purification 
      The long DNA region contains 8 different SNPs (rs2513787:8:94114852, 
rs2446824:8:94115346, rs2446823:8:94115384, rs149630836:8:94115608, 
rs2513788:8:94115668, rs2513789:8:94115885, rs2513790:8:94115919, 
rs2446821:8:94116251) that are in linkage disequilibrium and located in 5’ end of the 
CDH17 gene was amplified by PCR. The primers were designed according to the 
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human genome. The DNA sample of an OA patient with heterozygotes was selected as 
PCR template. PCR amplification was carried out with the reaction mixture composed 
of 1 µl of diluted DNA sample of OA patient, 2.5 µl of gene-specific forward primer (5 
µM) and reverse primer (5 µM) (see Table 3 for the list of primer sequences), 1.5 µl of 
MgCl2 (25 mM), 0.5 µl of dNTP (10 mM), 5 µl of 5x PCR buffer, and 0.25 µl of Go 
Taq® DNA polymerase (5 u/µl, Promega) with the final volume adjusted to 25 µl with 
ddH2O. Amplification was carried out in a thermal cycler with 5 minutes of 
denaturation at 94°C, followed by 35 cycles of 30 seconds of denaturing at 94°C, 1 
minute and 30 seconds of annealing at 59°C, 1 minute of extension at 72°C with a final 
extension at 72°C for 10 minutes. A negative control was always included and the 
amplified products were mixed with loading buffer and separated on a 1% agarose gel 
and stained with 1:10,000 diluted RGB nucleic acid stain (Phenix). The gel that 
contained PCR amplified products was cut by scalpel accordingly and purified by using 
QIAquick® Gel Extraction Kit (QIAGEN, Valencia, CA) following the manufacturer’s 
instructions. The purified products then were diluted by 30 ul ddH2O, and the 
concentration was measured by NanoDrop™ 2000 Spectrophotometer. 
 
TA cloning and double digestion 
      The pGEM®-T Easy Vector (Promega, Madison, WI, USA) was used as the 
vector for cloning PCR amplified products. Insert and vector were incubated with 2X 
Rapid Ligation Buffer and T4 ligase (Promega, 3 u/µl) overnight at 4°C. The 
Escherichia coli competent cells (Novagen) (> 1.5 x 108 CFU/µg) were transformed 
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with 1 µl of ligation mixture using a heat shock method involving incubation on ice for 
5 minutes, followed by a heat shock for 30 seconds in a 42°C water bath, and then on 
ice for another 2 minutes. The transformation mixture was plated on LB 1% 
carbenicillin agar plates. Plates were incubated overnight at 37°C. Four clones were 
selected and inoculated in 3 ml of LB broth with 1% carbenicillin overnight in shaking 
incubator at 37°C with 250 rpm. Plasmids were isolated from the overnight grown 
culture using a QIAprep miniprep plasmid isolation kit (QIAGEN, Valencia, CA) 
following the manufacturer’s instruction. The isolation products later were sent to DNA 
sequencing with T7 and SP6 primers. The double digestion performed by adding 2.5 ul 
of each XhoI and KpnI enzyme. Five µl of restriction buffer 1.1 was used according to 
the information from Double Digest Finder (www.neb.com). All the enzymes, buffer 
1.1 and 2.5 µg of the TA cloning sample was added into 1.5 ml Eppendorf tube with the 
final volume adjusted to 50 µl with ddH2O (For each of TA cloning sample). The tubes 
later were sent to 37℃ incubators for 3 hours. After 3 hours incubation, the digestion 
samples were added with loading buffer and separated on a 1% agarose gel and stained 
with 1:10,000 diluted RGB nucleic acid stain (Phenix). The double digestion result was 
observed by comparing 1kb ladder (NEB, Ipswich, MA, USA). The restriction products 
again were purified by using QIAquick® Gel Extraction Kit (QIAGEN, Valencia, CA) 






Cloning of expression reporter constructs 
      The pGL3-promoter Firefly Luciferase reporter vector (Promega, Madison, WI, 
USA) was selected as the final reporter assay vector through comparing with other 
similar reporter vectors. The detailed information of pGL3-promoter Firefly Luciferase 
reporter vector is shown in Figure 3. Then, 0.25 µg of pGL3 reporter vector was 
digested by 2.5 µl of each XhoI and KpnI enzyme and 5 µl of restriction buffer 1.1 into 
the total volume adjusted to 50 µl with ddH2O and then kept into 37℃ incubators for 3 
hours. The product was added with loading buffer and separated on a 1% agarose gel 
and stained with 1:10,000 diluted RGB nucleic acid stain (Phenix). All the SNPs 
fragments and the PCR amplified product were used as inserts for cloning. The ligations 
were made with 3:1 molar ratio for the insert ratio to the vector. Two µl of T4 DNA 
Ligase Buffer (10X) (Promega) was used to each of reactions and 1 µl of T4 ligase 
(Promega, three u/µl) was added at the last steps of reaction with the final volume 
adjusted to 20 µl for each of reactions. All the cloning samples were incubated in 4℃ 
overnight. Escherichia coli competent cells (Novagen) (> 1.5 x 108 CFU/µg) were 
transformed with 1 µl of ligation mixture using a heat shock method involving 
incubation on ice for 30 minutes, followed by a heat shock for 30 seconds in a 42°C 
water bath, and then on ice for another 2 minutes. The transformation mixture was 
plated on LB 1% carbenicillin agar plates. Plates were incubated overnight at 37°C. 
Eight clones of each plate were selected and restricted on LB 1% carbenicillin agar 
plates for inoculation after PCR checking. Simultaneously, eight clones of each plate 
also were used as a template for cloning PCR to check if cloning were a success or not. 
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For cloning PCR, forward primers were all forward oligonucleotides of each SNPs, 
reverse primer was designed as a universal primer that located at the shared sequence 
of pGL3 reporter vector. Each pair of primers were specifically generated a short 
fragment around 205 bp for the 23 SNPs and 1496 bp for long fragments if the ligations 
were succeeded. PCR amplification was carried out in a thermal cycler with 5 minutes 
of denaturation at 94°C, followed by 35 cycles of 30 seconds of denaturing at 94°C, 1 
minute and 30 seconds of annealing at 59°C, 1 minute of extension at 72°C with a final 
extension at 72°C for 10 minutes. Figure 4 shows some examples of how plates were 
designed as eight pieces for eight clones and the cloning PCR results on 1% agarose 
gel. The verified clones were inoculated the next day and cultured in 3 ml of LB broth 
with 1% carbenicillin overnight in shaking incubator at 37°C with 250 rpm. Plasmids 
were isolated from the overnight grown culture using a QIAprep miniprep plasmid 
isolation kit (QIAGEN, Valencia, CA) and QIAfilter plasmid midi kit (QIAGEN, 
Valencia, CA) following manufacturer’s instructions. The plasmids isolated with the 
mini kit were then sent to DNA sequencing.   
 
Cell Culture and Transfection 
      A549 cells were cultured in DMEM–Dulbecco's Modified Eagle Medium 
(Promega, Madison, WI, USA), supplemented with 10% fetal calf serum (Life 
Technologies). A549 cells were digested by trypsin for 5 minutes at 37℃ when it 
covered plate surface nearly 100%. Then A549 cells were plated in 96 well plates one 
day before transfection. The amount of each cell in each well was adjusted according 
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to transfection protocol. Transfections was carried out with Lipofectamine® LTX 
Reagent (Invitrogen, CA). Each of the Pgl3-Promoter Vector containing the each 
specific SNP (180 ng) was co-transfected with 20 ng of pRL Renilla Luciferase Control 
Reporter Vectors pRL-CMV, (Promega, Madison, WI, USA). All the processes of cell 
culture and transfection were conducted under sterile condition.  
 
Luciferase Assay 
      Luciferase activity was measured using the Dual-Luciferase Assay System 
(Promega, Madison, WI) following the manufacturer’s instructions. Briefly, after 
transfection, cells were incubated at 37 °C in a CO2 incubator for 48 hours. Cells were 
then lysed in the buffer provided by the manufacturer and mixed on a shaker for 15 min 
at room temperature. The firefly and renilla luciferase activities of the cell lysates were 
measured separately on a Synergy HT 96 microplate luminometer (Biotech, Winooski, 
Vermont, USA).  
 
Statistics analysis 
      All experiments were performed at least three times. To normalize luciferase 
activities, the renilla luciferase activities were measured as normalization reference. 
Shapiro-Wilk W test was made to make sure that the residuals of expression data are 
normally distributed across their treatment means at α=0.05. Comparisons were 
performed using Fisher’s least significant difference (LSD) test following one-way 
analysis of variance (ANOVA) for the different groups. We also did Benjamini-
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Hochberg adjustment (Q=0.1) for all the normalized data in order to control the false 






Cloning of haplotypes of CDH17-1469bp long fragments  
        The DNA sample of an OA heterozygous patient was used as a template for 
PCR amplification of the CDH17-1469 bp long fragments. The primers were designed 
to flank the two sides of the target region. The sequences of primers are shown in Table 
3. The size of PCR product was around 1500 bp indicating that the PCR worked. The 
PCR product was purified and used as the insert for TA cloning. Because the 
amplification of the CDH17-1469 bp fragment was based on a heterozygous template, 
two different haplotypes were expected. To identify two different haplotypes, plasmids 
from four colonies were isolated for DNA sequencing. The two different haplotypes of 
CDH17-1469bp were verified by sequencing analysis (CDH17-1469-OA11-2: C allele 
for rs2513787 and G for rs2446821; CDH17-1469-OA11-4: An allele for rs2513787 
and T for rs2446821). For further reporter assay construct cloning, the sticky restriction 
sites of two haplotypes CDH17-1469-bp long fragments were made through double 
digestion (Figure 4).  
Cloning of the reporter assay construct 
The 23 SNP short fragments and two haplotypes CDH17-1469-bp long 
fragments were cloned into the pGL3-promoter Firefly Luciferase reporter vector 
(Figure 5A). To ensure cloning success before plasmid isolation, colony PCR for each 
fragment was performed. An example of colony PCR result is shown in Figure 5B 
(Other 46 samples were also made); the CDH17-1469-bp long fragments colony PCR 
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result is shown in Figure 5C. The expected band sizes of PCR products means cloning 
of the reporter assay construct was successful. Isolations of all plasmids were made and 
sent for DNA sequencing. All the sequences of clones prepared in pGL3-promoter 
Firefly Luciferase reporter vector were confirmed by DNA sequencing.  
Quantitative analysis of Luciferase assay 
      The A549 cell line was cultured in DMEM with fragments transfection. The 23 
short fragments and the two haplotypes of the CDH17-1469-bp long fragments were 
transfected with the pRL renilla luciferase control reporter vectors into the A549 cell 
line. The luciferase activities were measured 48 hours after transfection. Statistical 
analyses were used according to normalized data: 23 SNPs normalized luciferase 
activity values indicated each SNP normalized luciferase activity data was normally 
distributed through the Shapiro-Wilk W test with treatment means at a α=0.05. CDH17-
1469-OA11 long fragments normalized luciferase activity values also were normally 
distributed. With normally distributed data points, an one-way analysis of variance 
(ANOVA) is appropriate. 
SNPs associated with di-isocyanate asthma   
To determine if any SNP affected transcription factor binding, we used Fisher’s 
least significant difference (LSD) test following by one-way analysis of variance 
(ANOVA) and Benjamini-Hochberg adjustment (Q=0.1) for all the normalized data. 
We found 3 SNPs out of 23 SNPs (T vs. C for rs11571537, A vs. G for rs2287231, and 
A vs. G for rs2446824) have significant difference in normalized luciferase activities 
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between risk and non-risk alleles (*p < 0.025, *p < 0.01, *p < 0.01), as Figure 6A, 
Figure 6B and Figure 6C show respectively. The two haplotypes of CDH17-1469-OA11 
showed no significant difference between each other, but both haplotypes showed 
significant difference expression level (*p < 0.01) compare to the pGL-3-promoter 
control group  (Figure 6D). We were unable to find any significant difference for the 
rest of the 20 SNPs (Figure 7). These findings support the hypothesis that some SNPs 








      Occupational asthma is an inflammatory disease caused by environmental and 
genetic factors. Some studies identified and characterized the interaction between SNPs 
and inflammatory disease (Kim et al., 2009) (Tokuhiro et al., 2003). Based on GWAS 
research before, one hundred and forty-three SNPs were identified that show 
association with DA, of which all but one SNP were located in intronic regions. From 
transcriptomic analysis that used available transcription factor (TF) datasets from 
relevant lung-derived tissues and cell lines, including ChIP-seq datasets for TFs, 
regulatory histone markers, and DNase-seq (open chromatin), the top-ranked 23 SNPs 
were identified based on the number of datasets they overlap and the biological 
relevance of the associated SNPs (Lummus et al., 2017). Based on the locations of the 
23 SNPs, many of them are located near to each other, so we also designed two 
haplotypes long fragments containing those linked SNPs as two new samples. The 
possible roles of these variants on gene expression and protein function are under 
investigation in separate study. In this study, out of these 23 SNPs, we identified 3 SNPs 
that may be considered as genetic factors related with DA. 
      The SNP rs2287231 is located upstream of the TAR1 gene. TAR1 was found in 
mitochondria, coded within the 25S rRNA gene on the opposite strand. It may be 
involved in mtDNA stability or mitochondrial gene expression regulation at the post-
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transcriptional level (Coelho, 2002). It seems like TAR1 gene has no interaction with 
OA. Nevertheless, the TAR1 protein may interact with other proteins as a co-activator.  
The SNP rs2446824 is located downstream of CDH17 gene. This gene belongs 
to the cadherin superfamily that encodes calcium-dependent, membrane-associated 
glycoproteins. In human, CDH17 gene encodes cadherin 17 protein, which is a 
component of the gastrointestinal tract and pancreatic ducts. This protein may play an 
important role in the morphological organization of liver and intestine 
(Ncbi.nlm.nih.gov, 2017). Perhaps the shape of pancreatic ducts has some influence on 
OA. A GWAS study also indicated that SNP (rs2514805) near the CDH17 genes on 
chromosome 8 has a significant association with DA (Yucesoy et al., 2015). This 
evidence suggests CDH17 gene expression may be affected by SNPs near the CDH17 
gene. Although both SNP rs2287231 and SNP rs2446824 are not located on promoter 
regions, transcription regulation is not a simple process of binding transcription factors 
with promotor. The recruitment of proteins that contain different function is a critical 
step for a successful transcription. Therefore, SNPs around a gene may also affect the 
regulation of gene expression.  
      The SNP rs11571537 locates on the first intron of activating transcription factor 
3 (ATF3) gene. ATF3 is a member of the ATF/cyclic AMP response element-binding 
family of a transcription factor. The ATF family represents a large group of basic-
region leucine zipper (bZIP) transcription factors. The common feature of the ATF 
family is they all can use bZIP to form homodimers or heterodimers with other bZIP 
31 
 
that contains other proteins to recognize specific DNA binding in the basic region (Hai, 
2006). Since ATF3 most times has to work with other proteins, it is hard to define it as 
an activator or repressor (Hai et al., 1999). Studies point out negative feedback 
regulation of ATF3 as the key to protect acute inflammatory syndromes through 
limiting pro-inflammatory cytokine expression, and ATF is critical in the suppression 
of inflammatory responses to infection and allergy (Whitmore et al., 2007). The most 
remarkable research that connects with our study is in a mouse model of ovalbumin 
allergen-induced asthma. ATF3 expression was shown to be significantly increased 
(Gilchrist et al., 2008). From these data, it is clear that the ATF3 gene plays an important 
role in the inflammatory disease. More specifically, it has a connection with OA. ATF3 
acts like a switch for stimulating transcription processes by preventing the access of 
inhibitory co-factors to gene promoter. It is possible that alternative splicing of the 
ATF3 gene can be physiologically critical in the regulation of target genes.  
In this study, we only studied the SNPs at the gene expression level without 
protein expression level research. The magnitude of difference in transcriptional 
processes cannot be defined. Based on these data, further research on DA can determine 
if the identified risk SNPs are located in any putative transcription elements that may 
affect the binding of the relevant transcription factors. The transcription element search 
software [(TESS) http://www.cbil.upenn.edu/tess/] can analyze the promoter sequence 
of this three genes, and the electrophoretic mobility shift assay (EMSA) can measure 
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the capacity of any identified transcription elements to bind candidate transcription 
factors and to investigate the influence of variations on transcription factor binding. 
      In addition, the long fragment CDH17-1469bp-OA11 that contains eight SNPs 
is a test model that we may use for the future research. According to the description of 
eukaryotic transcription regulation (Krebs et al., 2014), we believe the transcription of 
a specific gene can be regulated by more than one SNP. A haplotype, more specifically, 
probably decides the amount of gene expression more than just one SNP. Even these 
two haplotypes in this study did not show a significant difference. The higher 
expression than original pGL3-promoter reporter vector still indicates expression level 
changed because of the participation of eight SNPs. The more groups of haplotypes will 
be tested in the future.  
      In conclusion, our data indicate that these three SNPs (rs11571537, rs2287231, 
and rs2446824) located inside of ATF3 gene, upstream of TAR1 gene and downstream 
of CDH17 gene, respectively, cause a significant difference in luciferase activities 
between risk and non-risk alleles (C vs. T for rs11571537, A vs. G for rs2287231, and 




Tables and Figures 
Table 1.  Top ranked SNPs associated with di-isocyanate-induced occupational 
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1.583248 3.026485 
 
*Single Nucleotide Variant 
&p values for DA+ occupational asthma cases (n=91) compared to diisocyanate exposed asymptomatic 






































Table 2.  SNPs for which transcription factor binding sites have been identified 























+ downstream 6000 bp upstream 
of  ATF3; lots of 
TFs and histone 
marks - potential 
'super-enhancer'; 
Inside TCF12 ChIP 
peak, predicted to 




2 rs72756369 ATF3 + Inside gene  P130 
3 rs11571537 ATF3 + Inside gene inside ATF3 1st 
intron - lots of 




4 rs11571559 ATF3 + downstream  SpI1,RUNX1, 
POLR2A 
5 rs11571563 ATF3 + downstream inside RUNX peak, 
has a predicted 
RUNX site nearby 
 
RUNX1, POLR2A 
6 rs74138575 ATF3 + downstream inside RUNX peak, 
but no predicted 




7 rs75465959 ATF3 + downstream inside RUNX peak, 
but no predicted 
RUNX binding site 
nearby; inside 
TCF12 ChIP peak, 
and predicted to 




8 rs147978008 FAM71A 
 
+ upstream  SPI1, POLR2A 
9 rs17019510 FAM71A 
 
+ downstream  USF1 
10 rs2287231 TACR1 
 
- upstream  SPI1 
11 rs2446824 CDH17 - downstream  SPI1, CEPBP 
12 rs2446823 CDH17 - downstream  SPI1,  POLR2A 
13 rs149630836 CDH17 - downstream Risk allele is a 6 bp 
deletion 
RELA, SPI1, EP300, 
CEPBP,FOSL2 
14 rs2513788 CDH17 - downstream  inside CDX2 ChIP 
peak, and predicted 
to affect CDX2 
binding 
 
RELA, SPI1, EP300, 
CEPBP,FOSL2 
15 rs2513789 CDH17 - downstream  SPI1, CEPBP,FOSL2 
16 rs2513790 CDH17 - downstream P130 
17 rs2446821 CDH17 - downstream  SPI1,P130 
18 rs2513791 CDH17 - downstream  P130 
19 rs117579120 CDH17 
- 
Inside gene  SPI1, EP300 
20 rs2251996 CDH17 - Inside gene potentially right 
inside a RUNX binding 
site (70% match)   
 
RUNX1 
21 rs1672692 ZBTB16 
 
+ Inside gene ~10 bases away from 




22 rs62084077 PITPNC1 
 
+ Inside gene inside 1st intron; 
lots of TFs binding 
here; inside MAX 
ChIP peak, and 
predicted to alter 














Primer name Primer sequences 
Regular 
PCR 





































































Table 4. Sequence of oligos used for preparation of SNP fragments  
 
 
SNP Variant Design SNP Variant Design 
1LOC 
 








     CGAATTGCCTACTATCTCAGTAGCCCACCATC 
 
CATGGCTTAACGGATGATAGAGTCATCGGGTGGTAGAGCT 






















































































































     CAGTCAGCTCAGGCCAACATAACAAAATACCAC 
 
CATGGTCAGTCGAGTCCGGTTGTATTGTTTTATGGTGAGCT 


























































































































































































Figure 1. Bioluminescent reactions catalyzed by firefly and Renilla luciferases. 
Photon emission is achieved through oxidation of beetle luciferin in a reaction that 
requires ATP, Mg2+, and O2. This assay chemistry generates a “flash” of light that 
rapidly decays after the substrate and enzyme are mixed. The luminescent reaction 
catalyzed by Renilla luciferase utilizes O2 and coelenterate luciferin. (Protocol of Dual-


















Figure 2. An example of an SNP fragment design. According to the information from 
dbSNP of NCBI (https://www.ncbi.nlm.nih.gov/snp), the name, location, sequence and 
detail information of an SNP are showed on top. The two restriction sites were added 
at each end of two alleles with sticky ends. The blue parts are the two alleles of one 
SNP. The yellow parts at each sequence ends are restriction sites; the yellow middle 
parts are the SNP variant. The sequences followed by red parts are fragments that need 








Figure 3. The pGL3-Promoter Vector circle map.  The luc+ can encode the 
modified firefly luciferase; Ampr, gene conferring ampicillin resistance in Escherichia 
coli; f1 ori, origin of replication derived from filamentous phage; ori, origin of plasmid 
replication in E. coli. Arrows within luc+ and the Ampr gene indicate the direction of 



















Figure 4. Double digestion of CDH17-1469-OA11-2 and CDH17-1469-OA11-4. The 
double digestion was analyzed on a 1% agarose gel. The two bands around 1500 bp 
proved the CDH17-1469-OA11-2 and CDH17-1469-OA11-4 were digested 





















Figure 5. Cloning of the reporter constructs and colony PCR. A. Cloned luciferase 
reporter constructs containing the SNPs. Gray boxes, the 3’UTR used in the reporter 
constructs that contain the target SNPs or the long SNPs fragment. Red star 
representsthe risk allele of each SNP that may affect expression level change. Red box, 
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the long fragment that contains multiple SNPs, represented a haplotype. B. The colony 
PCR amplification using eight different single colonies that possibly have cloned report 
construct as templates showed single band around 250 bp, indicating that the cloning 
of report constructs are of good quality and ready for DNA sequencing. All the 46 
clones were tested before DNA sequencing. C. The colony PCR amplification using 
eight different single colonies that possibly have cloned reporter construct as templates 
showed single band around 1500 bp, indicating that the cloning of reporter constructs 









































































































































Figure 6. Normalized luciferase activities of SNPs and CDH17-1469 bp long 
fragments.  A. Normalized luciferase activities of SNP rs11571537 between risk and 
non-risk alleles (C vs. T). Significant difference between two alleles was observed by 
Fisher’s least significant difference test following one-way analysis of variance 
(Difference [D], 0.2880018; 95% Confidence interval [CI], 0.038-0.540, p = .025).  B. 
Normalized luciferase activities of SNP rs2287231 between risk and non-risk alleles (A 
vs. G). Significant difference between two alleles was observed by Fisher’s least 
significant difference test following one-way analysis of variance (Difference [D], 
0.4206311; 95% Confidence interval [CI], 0.088-0.752, p = .01).  C. Normalized 
luciferase activities of SNP rs2446824 between risk and non-risk alleles (T vs. C). 
Significant difference between two alleles was observed by Fisher’s least significant 
difference test following one-way analysis of variance (Difference [D], 0.2407542; 95% 
Confidence interval [CI], 0.059-0.423, p = .01).  D. Normalized luciferase activities 
of CDH17-1496bp-OA11 between two haplotypes. No significant difference between 
two haplotypes was observed by Fisher’s least significant difference test following one-



















































































































































































































































































































































































































































































































































































































































Figure 7. Relative luciferase activities of SNPs that have no significant difference. 
Relative luciferase activities of all SNPs above were analyzed by student t-test. No 
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